Arch Biopartners Inc
XTSX:ARCH

Watchlist Manager
Arch Biopartners Inc Logo
Arch Biopartners Inc
XTSX:ARCH
Watchlist
Price: 1.27 CAD -0.78%
Market Cap: 85m CAD

Relative Value

There is not enough data to reliably calculate the relative value of ARCH.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ARCH Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
4
Median 3Y
24.4
Median 5Y
41.5
Industry
4
Forward
41.6
vs History
vs Industry
Median 3Y
-29.7
Median 5Y
-29.5
Industry
31.9
Forward
-17.7
vs History
vs Industry
100
Median 3Y
-45.2
Median 5Y
-45.2
Industry
19.6
vs History
vs Industry
100
Median 3Y
-59.4
Median 5Y
-57.6
Industry
26.9
vs History
vs Industry
Median 3Y
-22.4
Median 5Y
-23.8
Industry
2.8
vs History
vs Industry
3
Median 3Y
25.1
Median 5Y
44.2
Industry
4
Forward
42.7
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.9
vs History
vs Industry
Median 3Y
-33.2
Median 5Y
-30.3
Industry
18.9
Forward
-7.1
vs History
vs Industry
Median 3Y
-33.2
Median 5Y
-30.3
Industry
24.1
Forward
-6.4
vs History
vs Industry
100
Median 3Y
-46.2
Median 5Y
-46.2
Industry
20.3
vs History
vs Industry
100
Median 3Y
-46.2
Median 5Y
-46.2
Industry
26.9
vs History
vs Industry
100
Median 3Y
-118.8
Median 5Y
-98.1
Industry
2.3

Multiples Across Competitors

ARCH Competitors Multiples
Arch Biopartners Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Arch Biopartners Inc
XTSX:ARCH
84m CAD -991.2 -35.2 -41.9 -41.9
US
PerkinElmer Inc
LSE:0KHE
1.1T USD 402.1 4 763.8 1 397.1 2 806.8
US
Thermo Fisher Scientific Inc
NYSE:TMO
230.9B USD 5.3 35.2 24.9 32.2
US
Danaher Corp
NYSE:DHR
166.6B USD 6.9 47.5 25.4 38.5
CH
Lonza Group AG
SIX:LONN
38.2B CHF 5.4 52.2 39.7 39.7
US
Agilent Technologies Inc
NYSE:A
41.7B USD 6 32 24.7 29.5
US
IQVIA Holdings Inc
NYSE:IQV
41.6B USD 2.6 32.4 15.5 23.2
CN
WuXi AppTec Co Ltd
SSE:603259
283.4B CNY 6.4 18.9 21.5 21.5
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW 8.4 29 16.9 22.5
US
Mettler-Toledo International Inc
NYSE:MTD
30B USD 7.6 35.9 25.8 28.6
FR
Sartorius Stedim Biotech SA
PAR:DIM
21B EUR 7.1 79.2 28.1 46.2
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Arch Biopartners Inc
XTSX:ARCH
Average EV/EBITDA: 162
Negative Multiple: -41.9
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 397.1
5%
279.4
US
Thermo Fisher Scientific Inc
NYSE:TMO
24.9
6%
4.2
US
Danaher Corp
NYSE:DHR
25.4
5%
5.1
CH
Lonza Group AG
SIX:LONN
39.7
18%
2.2
US
Agilent Technologies Inc
NYSE:A
24.7
13%
1.9
US
IQVIA Holdings Inc
NYSE:IQV
15.5
8%
1.9
CN
WuXi AppTec Co Ltd
SSE:603259
21.5
30%
0.7
KR
Samsung Biologics Co Ltd
KRX:207940
16.9
20%
0.8
US
Mettler-Toledo International Inc
NYSE:MTD
25.8
4%
6.4
FR
Sartorius Stedim Biotech SA
PAR:DIM
28.1
19%
1.5
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Arch Biopartners Inc
XTSX:ARCH
Average EV/EBIT: 308.9
Negative Multiple: -41.9
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
2 806.8
29%
96.8
US
Thermo Fisher Scientific Inc
NYSE:TMO
32.2
15%
2.1
US
Danaher Corp
NYSE:DHR
38.5
16%
2.4
CH
Lonza Group AG
SIX:LONN
39.7
22%
1.8
US
Agilent Technologies Inc
NYSE:A
29.5
23%
1.3
US
IQVIA Holdings Inc
NYSE:IQV
23.2
15%
1.5
CN
WuXi AppTec Co Ltd
SSE:603259
21.5
23%
0.9
KR
Samsung Biologics Co Ltd
KRX:207940
22.5
28%
0.8
US
Mettler-Toledo International Inc
NYSE:MTD
28.6
5%
5.7
FR
Sartorius Stedim Biotech SA
PAR:DIM
46.2
31%
1.5